Dorothée Selimoglu-Buet

7PUBLICATIONS
32CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMedical infection agents (incl. prions)Tumour immunologyMedical mycologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini

|Nov 23, 2024
Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways.

Donia Hidaoui, Audrey Porquet, Rabie Chelbi

|Nov 08, 2022
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia.

Awatef Allouch, Laurent Voisin, Yanyan Zhang

|Feb 04, 2022
Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes.

Elodie Pronier, Aygun Imanci, Dorothée Selimoglu-Buet

|Mar 10, 2021
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML.

Margaux Sevin, Franck Debeurme, Lucie Laplane

|Jul 21, 2020
Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study.

Matthieu Jestin, Sihem Tarfi, Matthieu Duchmann

Pageof 2

Frequent Collaborators

6 joint publications

Nathalie M Droin

5 joint publications

Eric Solary

4 joint publications

Raphael Itzykson

3 joint publications

Orianne Wagner-Ballon